Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis

Eur J Pharmacol. 1988 Nov 8;156(3):385-93. doi: 10.1016/0014-2999(88)90284-1.

Abstract

The effect on dopamine (DA) release of D-1 and D-2 receptor agonists and antagonists applied locally in the caudate through a trans-striatal dialysis probe was studied in freely moving rats. D-2 agonists (LY 171555 and BHT 920) reduced DA release in a concentration-dependent manner. The same local application of haloperidol abolished the effect of 10 microM LY 171555 and BHT 920. A specific D-1 agonist, the catechol benzazepine SKF 38393, reduced DA release and this effect was not modified by systemic or local administration of the D-1 antagonist, SCH 23390, nor by the D-2 antagonist, haloperidol. In contrast, the non-catechol D-1 agonist, CY 208243, failed to modify DA release. Local application of the D-1 antagonist, SCH 23390, or of the D-2 antagonist, (-)-sulpiride, stimulated DA release in a concentration-dependent manner. The D-1 agonist, CY 20843, reversed the stimulatory effect of SCH 23390 but not that of (-)-sulpiride. It is concluded that D-1 and D-2 receptors located in the caudate control DA release separately in this area.

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Animals
  • Azepines / pharmacology
  • Benzazepines / pharmacology
  • Brain / drug effects
  • Brain / physiology
  • Dialysis
  • Dopamine / metabolism*
  • Dopamine Agents / pharmacology*
  • Dopamine Antagonists
  • Ergolines / pharmacology
  • Haloperidol / pharmacology
  • Male
  • Quinpirole
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine / drug effects*
  • Receptors, Dopamine / physiology
  • Sulpiride / pharmacology

Substances

  • Azepines
  • Benzazepines
  • Dopamine Agents
  • Dopamine Antagonists
  • Ergolines
  • Receptors, Dopamine
  • Quinpirole
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • talipexole
  • Sulpiride
  • Haloperidol
  • Dopamine